Century Therapeutics Statistics
Total Valuation
IPSC has a market cap or net worth of $53.54 million. The enterprise value is -$52.09 million.
Important Dates
The next estimated earnings date is Friday, November 7, 2025, before market open.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IPSC has 86.39 million shares outstanding. The number of shares has increased by 29.80% in one year.
| Current Share Class | 86.39M |
| Shares Outstanding | 86.39M |
| Shares Change (YoY) | +29.80% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 4.60% |
| Owned by Institutions (%) | 23.50% |
| Float | 45.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| Forward PS | n/a |
| PB Ratio | 0.25 |
| P/TBV Ratio | 0.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.72, with a Debt / Equity ratio of 0.25.
| Current Ratio | 10.72 |
| Quick Ratio | 10.47 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -10.78% and return on invested capital (ROIC) is -6.64%.
| Return on Equity (ROE) | -10.78% |
| Return on Assets (ROA) | -5.11% |
| Return on Invested Capital (ROIC) | -6.64% |
| Return on Capital Employed (ROCE) | -10.62% |
| Revenue Per Employee | $760,853 |
| Profits Per Employee | -$155,187 |
| Employee Count | 150 |
| Asset Turnover | 0.33 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IPSC has paid $1.77 million in taxes.
| Income Tax | 1.77M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.40% in the last 52 weeks. The beta is 1.79, so IPSC's price volatility has been higher than the market average.
| Beta (5Y) | 1.79 |
| 52-Week Price Change | -55.40% |
| 50-Day Moving Average | 0.53 |
| 200-Day Moving Average | 0.59 |
| Relative Strength Index (RSI) | 66.60 |
| Average Volume (20 Days) | 992,470 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IPSC had revenue of $114.13 million and -$23.28 million in losses. Loss per share was -$0.27.
| Revenue | 114.13M |
| Gross Profit | 4.09M |
| Operating Income | -28.66M |
| Pretax Income | -21.51M |
| Net Income | -23.28M |
| EBITDA | -15.62M |
| EBIT | -28.66M |
| Loss Per Share | -$0.27 |
Full Income StatementBalance Sheet
The company has $155.84 million in cash and $51.48 million in debt, giving a net cash position of $104.36 million or $1.21 per share.
| Cash & Cash Equivalents | 155.84M |
| Total Debt | 51.48M |
| Net Cash | 104.36M |
| Net Cash Per Share | $1.21 |
| Equity (Book Value) | 209.90M |
| Book Value Per Share | 2.43 |
| Working Capital | 145.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$114.77 million and capital expenditures -$142,000, giving a free cash flow of -$114.91 million.
| Operating Cash Flow | -114.77M |
| Capital Expenditures | -142,000 |
| Free Cash Flow | -114.91M |
| FCF Per Share | -$1.33 |
Full Cash Flow StatementMargins
Gross margin is 3.58%, with operating and profit margins of -25.11% and -20.40%.
| Gross Margin | 3.58% |
| Operating Margin | -25.11% |
| Pretax Margin | -18.85% |
| Profit Margin | -20.40% |
| EBITDA Margin | -13.69% |
| EBIT Margin | -25.11% |
| FCF Margin | n/a |
Dividends & Yields
IPSC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.80% |
| Shareholder Yield | -29.80% |
| Earnings Yield | -44.53% |
| FCF Yield | -219.83% |
Analyst Forecast
The average price target for IPSC is $3.33, which is 437.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.33 |
| Price Target Difference | 437.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IPSC has an Altman Z-Score of -2.16 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.16 |
| Piotroski F-Score | 3 |
